SpyGlass Pharma SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 19, 2026, 4:10 p.m. ETView on SEC.gov
Other events · Financial statements and exhibits
AI summary, unreviewedSpyGlass Pharma Reports Positive 4-Year First-in-Human Data for Bimatoprost Drug Pad-IOL System, Showing 37% IOP Reduction in N=21 Evaluable Patients
8-KOct. 1, 2026, 8:15 a.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits
10-QAug. 6, 2026, 4:37 p.m. ETView on SEC.gov
8-KAug. 6, 2026, 4:16 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits